Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-08-10
1986-02-04
Schwartz, Richard A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514227, 514259, 514264, 514267, 514277, 514307, 514343, 514356, 514396, 514399, A61K 3152, A61K 31505, A61K 31535
Patent
active
045686769
ABSTRACT:
A novel method of inhibiting blood platelet aggregation is disclosed which comprises the use of a CAMP inhibitor together with an inhibitor of thromboxane synthesis. While inhibitors of thromboxane synthesis are only weak inhibitors of platelet aggregation, the addition of only a small amount of a CAMP inhibitor has been found to result in a synergistic increase in the degree of platelet aggregation resulting from such combined additions. Marked increases over the otherwise expected culumative effects of these inhibitors have been demonstrated using combination of various thromboxane synthetase inhibitors and various CAMP inhibitors.
REFERENCES:
Chemical Abstracts, 89:123338m (1978) [Gorman, R., et al., Adv. Cyclic Nucleotide Res., 1978, 9, 597-609].
Chemical Abstracts, 81:33946p (1974) [Hugues, J., Acta Univ. Carol., Med., Monogr., 1972, 53/54, 179-184].
Rybicki, J., et al., Thrombosis Research, 30, 407-414 (1983).
Haslam, R., et al., Journal of Biochemistry, 176:83-95 (1978).
Lefkowitz, R., et al., TIPS, pp. 314-318 (Jul., 1980).
Smith, S., et al., Journal of Biological Chemistry, 257:10471 (1982).
Smith, J., Thrombosis Research, 28:477-485, 1982.
Macintyre, D., Platelets in Biology and Pathology-2, Chapter 9, Elsevier, New York, 1981, pp. 234-240.
Watanabe, T., et al., Journal of Biological Chemistry, vol. 257, pp. 14847-14853, 1982.
Rittenhouse, S., et al., Am. Soc. for Clin. Inves., 70:1216, 1982.
Hampton, J., et al., Cardiovascular Research, 1:101-107, (1967).
Mustard, J., et al., Biochemical Pharmacology, 22:3151-3156, (1972).
Kloeze, J., Biochim. Biophys. Acta, 187:185-292 (1969).
Smith, J., et al., Thrombosis Research, 5:291-299, (1974).
Johnson, R. A., et al, Prostaglandins, vol. 12, No. 6, pp. 915-928 (1976).
Gryglewski, R. J., et al., Thrombosis Research, vol. 13, No. 2, pp. 153-165 (1978).
Gorman, R. R., et al., Prostaglandins, vol. 13, No. 3, pp. 377-388 (3/1977).
Vigdahl, R. L., et al., Thrombosis Research, 21:547-555, (1981).
Fleming, J. S., et al., Thrombosis Research, 15: 373-388 (1979).
Ardlie, N. G., et al., Thromb. Diath. Haemorrh., 18:670-673, (1967).
Goodman et al, The Pharmacological Basis of Therapeutics, 6th Ed., Macmillian Pub. Co., New York, pp. 830 and 592-607 (1980).
Oelz, O., et al., Prostaglandins, vol. 13, No. 2, pp. 225-234 (Feb., 1977).
Hamberg, M., et al., Proc. Nat. Acad. Sci., USA, 71:3400-3404, (Sep., 1974).
Ellis, E., et al., Science, 193:1135-1137 (1976).
Needleman, P., et al., Proc. Natl. Acad. Sci, USA, vol. 74, No. 4, pp. 1716-1720 (1977).
Tyler, H. M., et al., The Lancet, pp. 629-632, (Mar. 21, 1981).
Taniguchi, K., et al., Int. Prostaglandin Conference, Washington, D.C., p. 82, 5/79.
Tai, C., et al., Int. Prostaglandin Conference, Washington, D.C., p. 115, 5/79.
Hampton, T., et al., Cardiovasc. Res., 1967, 1, 101-107.
Schwartz Richard A.
Thomas Jefferson University
LandOfFree
Method of inhibiting aggregation using thromboxane synthetase in does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of inhibiting aggregation using thromboxane synthetase in, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting aggregation using thromboxane synthetase in will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2341078